CalciCoach: Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT02664623
Collaborator
(none)
182
2
2
41.8
91
2.2

Study Details

Study Description

Brief Summary

The main objective of this study is to measure effectiveness at 6 months of personalized dietary advice versus dietary counseling via delivery of a standard advice sheet for optimizing dietary calcium intake (assessed by a food survey based on CIQUAL* data) in MS patients with ambulatory monitoring.

*CIQUAL Data: Table of nutritional food composition available on the ANSES (National Agency for Sanitary Security of Food, Environment and Labour) website, published by the Observatory of the Nutritional Quality of Foods. This table includes 1,500 sheets of 58 nutritional components. The data is integrated into the software for calculating ingesta (DATAMEAL) at the Nîmes University Hospital.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Individual dietary consultations
  • Procedure: Dietary advice sheet
N/A

Detailed Description

The secondary objectives of this study is to compare the two groups in order to:

A- correlate the impact of the recommendations by sheet or consult with disability, cognitive status, fatigue, depression, quality of life of patients with MS.

B- assess the prevalence of diet changes as an alternative therapy for lactose intolerance in the population and to correlate these changes with dietary calcium intake at baseline (assessed by a food survey based on CIQUAL* data).

C- assess calcium intake of the patients included via the self-administered frequency questionnaire QALCIMUM® on day 0 and 6 months and to compare them with data obtained by the food survey based on data from CIQUAL.

D- correlate calcium intake of the patients with vitamin D levels at inclusion and establish a biological collection of blood samples from the population.

Study Design

Study Type:
Interventional
Actual Enrollment :
182 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Personalized Nutrition Advice Delivered Via Dietary Consultations for Optimizing Dietary Calcium Intake in Patients With Multiple Sclerosis (MS) and Monitored as Outpatients: a Randomized, Single-blind, Bicentric Study
Actual Study Start Date :
Jul 13, 2016
Actual Primary Completion Date :
Jan 6, 2020
Actual Study Completion Date :
Jan 6, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dietary advice sheet

Patients in this arm will receive a dietary advice sheet at the beginning of the study. Intervention: Dietary advice sheet

Procedure: Dietary advice sheet
At the beginning neurological consult, patients will be delivered a dietary advice sheet called "Grio".

Experimental: Dietary advice sheet + consults with dietician

In addition to receiving a dietary advice sheet at the beginning of the study, patients randomized to this arm will have individual consultations with a dietician at inclusion, month 1 and month 3. Intervention: Dietary advice sheet Intervention: Individual dietary consultations

Procedure: Individual dietary consultations
Individual dietary consultations with a dietician will be held at inclusion, month 1 and month 3. Consults consist of a personal interview where the dietician delivers comprehensive information to the patient on how to optimize calcium intake and reduce the risk of fractures; the dietician questions the subject on his/her diet and reassesses the quality and quantity of calcium intake during the 3 days preceding the consultation through a survey calculation software based on data from CIQUAL.

Procedure: Dietary advice sheet
At the beginning neurological consult, patients will be delivered a dietary advice sheet called "Grio".

Outcome Measures

Primary Outcome Measures

  1. Calcium intake in mg per day [Day 0]

    Evaluation of calcium intake during a consultation with the dietician (CIQUAL data)

  2. Calcium intake in mg per day [Month 6]

    Evaluation of calcium intake during a consultation with the dietician (CIQUAL data)

Secondary Outcome Measures

  1. QALCIMUM questionnaire (mg/day) [Day 0]

  2. QALCIMUM questionnaire (mg/day) [Month 6]

  3. Expanded Disability Status Scale (EDSS) [Day 0]

  4. Expanded Disability Status Scale (EDSS) [Month 6]

  5. Paced Auditory Serial Addition Test [Day 0]

  6. Paced Auditory Serial Addition Test [Month 6]

  7. Hospital Anxiety and Depression Scale [Day 0]

  8. Hospital Anxiety and Depression Scale [Month 6]

  9. EQ-5D questionnaire [Day 0]

    EQ-5D™ is a standardised instrument for use as a measure of health outcome. (general health scale).

  10. EQ-5D questionnaire [Month 6]

    EQ-5D™ is a standardised instrument for use as a measure of health outcome. (general health scale).

  11. Mini Fatigue Impact Scale [Day 0]

  12. Mini Fatigue Impact Scale [Month 6]

  13. Dietary classification [Day 0]

    Patient diet classified as: normal; vegetarian, vegetalian; Seignalet; Kousmine; other.

  14. 25-hydroxy-vitamin D (D2 + D3) levels (nmol/L) [Day 0]

  15. 25-hydroxy-vitamin D (D2 + D3) plasma levels (nmol/L) [Month 6]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given his/her informed and signed consent

  • The patient must be insured or beneficiary of a health insurance plan

  • Patient with a confirmed diagnosis of remitting multiple sclerosis

  • Ambulatory patient (EDSS score < 6.5) who has never had a dietary consultation concerning the optimization of calcium intake

Exclusion Criteria:
  • The patient is participating in another non-observational study

  • The patient is in an exclusion period determined by a previous study

  • The patient is under judicial protection, under tutorship or curatorship

  • The patient refuses to sign the consent

  • It is impossible to correctly inform the patient

  • The subject is not able to complete a self-administered questionnaire

  • Vitamin D deficiency linked to currently active digestive or general diseases

  • Moderate or severe renal impairment (creatinine clearance <60ml / min)

  • Situations accompanied by increased vulnerability to hypercalcemia, eg arrhythmia or known heart disease, treatment with digitalis, subjects with nephrolithiasis

Contacts and Locations

Locations

Site City State Country Postal Code
1 CH d'Alès Alès France 30103
2 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09 France 30029

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Principal Investigator: Eric Thouvenot, MD, PhD, Centre Hospitalier Universitaire de Nîmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT02664623
Other Study ID Numbers:
  • LOCAL/2015/ET-02
  • 2015-A01618-41
First Posted:
Jan 27, 2016
Last Update Posted:
Jan 27, 2020
Last Verified:
Jan 1, 2020
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2020